Joseph G. Pressey · Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex
Follow
Article1 min read·Published Jan 2010Older

Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2010 · 1 min read

In brief

In brief

This case report demonstrates successful sirolimus therapy in a pediatric TSC patient with recurrent chest wall fibromatosis and bilateral multifocal renal cell carcinoma. mTOR inhibition achieved substantial tumor response within 6 months, avoiding bilateral nephrectomy while preserving renal function with minimal adverse effects.

Written by the GCMD Library team from the article.

Joseph G. Pressey

A male with tuberous sclerosis complex (TSC) developed a chest wall fibromatosis and bilateral multifocal renal cell carcinoma (RCC). The fibromatosis tumor was initially resected during infancy but recurred 5 years later. At that time, bilateral RCC was also detected, leading to the resection of the more extensively affected right kidney. In an attempt to avoid bilateral nephrectomies, the patient was treated with the mTOR inhibitor sirolimus. Within 6 months of therapy, the fibromatosis and remaining RCC tumors responded substantially with minimal adverse effects.

Statements in this article

  1. A male patient with tuberous sclerosis complex developed chest wall fibromatosis and bilateral multifocal renal cell carcinoma.

    Established
  2. The fibromatosis tumor recurred 5 years after initial resection during infancy.

    Research
  3. The more extensively affected right kidney was resected due to bilateral renal cell carcinoma.

    Research
  4. Sirolimus was used to avoid bilateral nephrectomies in this patient.

    Recommendation
  5. Within 6 months of sirolimus therapy, the fibromatosis and remaining renal cell carcinoma tumors responded substantially with minimal adverse effects.

    Research

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.